Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

421.50 -2.37 (-0.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 163,787
Open 426.63
Bid (Size) 412.00 (1)
Ask (Size) 445.00 (6)
Prev. Close 423.87
Today's Range 417.35 - 429.98
52wk Range 201.22 - 463.62
Shares Outstanding 17,103,395
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Beyond The Numbers: 10 Analysts Discuss Madrigal Pharmaceuticals Stock
 
Via Benzinga
6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner
Goldman Sachs has highlighted six stocks that have a high probability of being acquisition targets in the next year. 
Via Benzinga

Performance

YTD
+34.3%
+34.3%
1 Month
-1.3%
-1.3%
3 Month
+41.3%
+41.3%
6 Month
+29.0%
+29.0%
1 Year
+107.6%
+107.6%

More News

Read More
A Glimpse Into The Expert Outlook On Madrigal Pharmaceuticals Through 7 Analysts
Via Benzinga
MADRIGAL PHARMACEUTICALS INC (NASDAQ:MDGL) Screens as High-Growth Momentum Stock Meeting Minervini Trend Template
Via Chartmill
MarketBeat Week in Review – 09/08 - 09/12
Via MarketBeat
Topics Economy
Earnings Scheduled For August 5, 2025
Via Benzinga
Earnings Scheduled For May 1, 2025
Via Benzinga
General Motors To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
A Glimpse Into The Expert Outlook On Madrigal Pharmaceuticals Through 6 Analysts
Via Benzinga
CoreWeave and Madrigal's Insider Trades Flash Bullish Signals
Via MarketBeat
Topics Artificial Intelligence
Novo Nordisk Eyes New Arena Amid Weight-Loss Market Pressure
Via Investor's Business Daily
Gyre Therapeutics Gains Attention As Under-The-Radar Liver Fibrosis Drug Maker
Via Benzinga
Madrigal Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Corporate Wins: Intel, Palo Alto Networks, and Novo Nordisk Drive Market Optimism
Via MarketMinute
Topics Artificial Intelligence Economy
Novo Nordisk Pops On A New Wegovy Approval, Dragging Hard On Madrigal Pharma
Via Investor's Business Daily
Novo Nordisk's Wegovy Snags Conditional FDA Nod For Fatty Liver Disease
Via Benzinga
Billionaire Investor Buys Google And This Gold Miner Stock
Via Benzinga
Madrigal (MDGL) Q2 Revenue Soars 1,313%
Via The Motley Fool
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Beats Q2 2025 Revenue Estimates and Narrows Losses on Strong Rezdiffra Sales
Via Chartmill
European Advisory Panel Backs Conditional Approval For Madrigal's Fatty Liver Disease Drug
Via Benzinga
5 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years
Via The Motley Fool
Madrigal Pharma Short Interest Reaches 4-Month High: Retail Investors Still Bullish On Stock
Via Stocktwits
Topics Death
Uncovering Potential: Madrigal Pharmaceuticals's Earnings Preview
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is Madrigal Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Madrigal Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Madrigal Pharmaceuticals, Inc. - Common Stock trade on?
Madrigal Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock is MDGL on the Nasdaq Stock Market
What is the current price of Madrigal Pharmaceuticals, Inc. - Common Stock?
The current price of Madrigal Pharmaceuticals, Inc. - Common Stock is 421.50
When was Madrigal Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Madrigal Pharmaceuticals, Inc. - Common Stock was at 10/24/25 04:00 PM ET
What is the market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock is 7.21B
How many shares of Madrigal Pharmaceuticals, Inc. - Common Stock are outstanding?
Madrigal Pharmaceuticals, Inc. - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.